Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-up
- 1 March 1994
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 127 (3) , 674-682
- https://doi.org/10.1016/0002-8703(94)90679-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Markedly decreased coronary blood flow in secondary polycythemiaAmerican Heart Journal, 1992
- Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention TrialNew England Journal of Medicine, 1989
- Hemoglobin concentration and prognosis in symptomatic obstructive cerebrovascular disease.Stroke, 1987
- Hematocrit as a risk factor of cerebral infarction: long-term prospective population survey in a Japanese rural community.Stroke, 1986
- Cerebral blood flow is regulated by changes in blood pressure and in blood viscosity alike.Stroke, 1986
- Hemorheology of the cerebral circulation in stroke.Stroke, 1985
- Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health ProgramAmerican Heart Journal, 1981
- Of bloodlettingAmerican Heart Journal, 1979
- Importance of the hematocrit as a risk factor in cerebral infarction.Stroke, 1978
- Hemolobin and the Risk of Cerebral Infarction: The Framingham StudyStroke, 1972